EU Regulatory Submissions
Unlock the potential of the European market with our dedicated support for Marketing Authorisation Applications (MAA), Clinical Trial Applications (CTA), and Orphan Drug Designation Applications.
Whether pursuing centralised or decentralised approvals, our team is well-versed in the nuances of the European Medicines Agency (EMA) processes. Post-approval, we provide vigilant compliance support, managing variations and renewal applications to uphold marketing authorisation.
Trusted by top-tier teams worldwide
Marketing Authorisation Applications (MAA):
- End-to-end submission support
- Oral Explanation and CHMP meeting preparation
Clinical Trial Applications (CTA):
- CTA submissions across EU member states and centralised routes
- Regulatory query and protocol amendment support
Orphan Drug Designation Applications:
- Clinical trial design optimisation
- Post-approval orphan status maintenance
Post-Marketing Regulatory Compliance:
- Managing variations and PSURs
- Renewal applications and compliance checks
FAQs
We aim to make the process as simple to understand as possible and are always on hand to answer any questions you might have.
Here are some of the questions we get asked most often.
Our team has extensive experience in Advanced Therapy Medicinal Product (ATMP) clinical development and is well-versed in how to deliver compliance throughout the development process. Get in touch with us for further information.
Featured case studies
EU-IVDR Technical File Remediation
EU-IVDR Technical File Remediation Introduction In Vitro Diagnostic Manufacturer Our client is a leader in high-quality, innovative diagnostic products for the determination of blood groups (anti-Duffy and anti-Kidd). They are located in the US with operations globally. Standards & Tools EU-IVDR 2017-746 ISO 13485 ISO 14971 GDPR Word Excel Powerpoint Scope of work Key numbers…
Regulatory Strategy IVDR / FDA
Regulatory Strategy IVDR / FDA Introduction Deciphex Deciphex is a digital pathology workflow and integrated AI platform for research pathology, CROs and pharmaceutical companies for handling high volume drug safety pathology studies. They provide a complete GLP-compliant workflow with integrated AI screening capabilities. Standards & Tools Scope of work Brian – Director QA RA As…
Breakthrough Program
Breakthrough Program Introduction IVD manufacturer The company is a highly innovative IVD manufacturer start-up. Their device is CE marked and the client was looking to obtain FDA approval for sale on the US market. Apotech Consultants One consultant worked part-time on the project. The main focus was to design the rationale to be eligible for…
- « Previous
- 1
- 2
- 3
- Next »